Inc. today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). "We are pleased to see Abecma expansion in the third ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

Among 1,432 people with type 1 diabetes, high variability of average body weight was associated with a 25% higher risk of experiencing ... excretion rate 30-300 mg/24 hours) and severe albuminuria ...

Do Portugal Circus made its area debut last year when it set up its Big Top in the parking lot of the King of Prussia Plaza.

Tickets: https://www.seetickets.com/event/wilkinson-x-the-blast-present-sleepless-bristol/the-prospect-building/3229629 After two unbelievable Sleepless Bristol shows ...

Jo Good with late night conversation, amazing stories and the soundtrack to your night.

A new study has suggested that an overlooked nutrient that is easily added to the diet could reduce the risk of dementia and ...

Bristol Myers Squibb on Thursday posted better-than-expected fourth quarter earnings, but said its 2025 revenue would fall ...

Bristol Myers Squibb posted Q4 revenue of $12.34B, beating the consensus, with an 8% YoY increase driven by Growth Portfolio and Eliquis. Adjusted EPS was $1.67, topping the $1.46 consensus but ...

The study's authors stated: "Our findings suggest that moderate dietary choline intake, ranging from 332.89 mg/d to 353.93 mg/d, is associated with lower odds of dementia and better cognitive ...

(RTTNews) - While reporting financial results for the fourth quarter on Thursday, Bristol-Myers Squibb Co ... On average, 25 analysts polled expect the company to report earnings of $6.92 ...